This site is intended for healthcare professionals only

In association with the Cardiorenal Forum

Articles

  • Hospital laboratory worker

    Efficacy and safety of endothelin receptor antagonists in CKD: a meta‑analysis

  • Concept of doctors networking.

    A challenge for 2026 and beyond in cardiorenal medicine

  • Pharmacist at work

    Highlights of 2025: the rise of finerenone

  • Kidney anatomy concept

    FINE-HEART: Effects of finerenone on morbidity and mortality in CKD

  • Woman in consultation

    Defining the threshold of permissive renal function decline in heart failure

  • Associations between changes in kidney function and volume status with heart failure outcomes

  • Ethnic differences in CKD progression among people with type 2 diabetes

  • Growing CONFIDENCE in co-prescribing of SGLT2 inhibitors and non-steroidal MRAs

  • Combination finerenone and empagliflozin in CKD with diabetes

alt

For the latest news and articles
Sign up to Renal Review newsletters

Subscribe